Bangor Savings Bank’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
SI
GGI
QCM
DLA
MGIA
ERP
CCM
SIC
FPTW
Bangor Savings Bank's NVS Position: Q2 2026 in Review
Bangor Savings Bank reduced its Novartis (NVS) stake by 6.8% in Q2 2026, selling an estimated $62.8K and leaving 5,752 shares worth $901K. The position accounts for 0.07% of the portfolio, ranked #115.
Bangor Savings Bank first reported a position in NVS in Q3 2019 and has held it in 19 quarters since. The position peaked at $977K in Q3 2024. 264 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Bangor Savings Bank held 5,752 shares of Novartis worth $901K as of Q2 2026.
- Bangor Savings Bank sold 419 Novartis shares in Q2 2026, an estimated $62.8K.
- Novartis made up 0.07% of Bangor Savings Bank's portfolio in Q2 2026, its #115 holding.
- Bangor Savings Bank first reported a position in Novartis in Q3 2019 and has held it in 19 quarters since.
- Bangor Savings Bank's Novartis position peaked at $977K in Q3 2024.
- 264 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Bangor Savings Bank's 13F filing for Q2 2026, filed 6 Jul 2026.